Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon Alfa and Isotretinoin for Advanced Squamous Cell Carcinomas
NCT00002506Phase 2Completed
- Sponsor
- Hoag Memorial Hospital Presbyterian
- Start
- Aug 1992
- Primary completion
- Jan 1996
- Modality
- Cytokines & Interferons, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of interferon alfa and isotretinoin in squamous cell carcinoma (SCC), sponsored by Hoag Memorial Hospital Presbyterian. Primary endpoint: Response rates to treatment. Started Aug 1992; status: completed.
02
Drugs
interferon alfaisotretinoin
03
Conditions
squamous cell carcinoma (SCC)
Beyond the preview
Go deeper on NCT00002506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002506.